Intellia Share Price

Intellia Share Price

NASDAQ: NTLA | Small Cap | Healthcare
$10.04
+$0.49 (5.13%) Last updated on 21 Nov, 2026 | 02:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Intellia Stock Performance

Open
$9.34
Prev. Close
$9.55
Circuit Range
N/A
Day Range
$9.32 - $10.39
Year Range
$7.95 - $18.48
Volume
7,46,539
Average Traded
$10.10

Intellia Share Price Today

As of 21 November 2026, Intellia Therapeutics, Inc.'s share price is $10.04. The stock opened at $9.34, compared to its previous close of $9.55. During today's trading session, Intellia Therapeutics, Inc.'s share price traded between $9.32 and $10.39, with an average price of $9.86. Over the past 52 weeks, the stock has recorded a high of $18.48 and a low of $7.95. In terms of performance, Intellia Therapeutics, Inc.'s share price has declined by 28.64% over the last six months and is up 11.68% on a year-on-year basis.

Intellia Share Price Chart

Line chart of the Intellia price trend over the selected period. The price rose overall, ranging from 9.37 to 10.39, ending at 10.05.
$9.32$10.39
L
Show Current Price
H

Intellia Stock Fundamentals & Key Indicators

Market Cap
$1.09B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.04
Revenue (TTM)
$67.67B
Return On Equity (TTM)
-69.51%
Profit Margin
-609.86%
Debt to Equity
0.12
Quarterly Earnings Growth YoY
-33.09%

Intellia Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$23.02$15.05$7.66$7.16
Net Profit-$95.79-$96.23-$106.63-$127.49
Net Profit Margin-416.12%-639.40%-1392.04%-1780.59%
Income ChangeN/A-0.46%-10.81%-19.56%

Intellia Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$52.12$36.28$57.88$67.67
Net Profit-$474.19-$481.19-$519.02-$412.69
Net Profit Margin-909.80%-1326.32%-896.72%-609.86%
Income ChangeN/A-1.48%-7.86%20.49%

Intellia Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets314.42551.15302.65303.32
Current Assets527.71639.86998.331216.8
Total Assets842.131191.021300.981520.11
Non Current Liabilities66.85208.21135.6157.98
Current Liabilities103.88110.85115.21126.55
Total Liabilities170.73319.06250.81284.53
Shareholders' Equity671.39871.961050.171235.58

Intellia Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-394.74-348.88-394.09-346.77
Investing228.03125.57-31.35160.31
Financing131.49185.75130.32596.44

About Intellia

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Intellia Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$12.56
$10.03
-19.47%
Oct 2026
$11.90
$12.46
+3.23%
Sep 2026
$12.54
$12.06
-7.90%
Aug 2026
$10.64
$13.10
+22.66%
Jul 2026
$17.15
$10.68
-36.92%
Jun 2026
$13.78
$16.93
+20.33%
May 2026
$13.27
$14.07
+4.49%
Apr 2026
$13.03
$13.46
+5.11%
Mar 2026
$13.80
$12.81
-7.04%
Feb 2026
$13.01
$13.78
+4.91%
Jan 2026
$9.21
$13.13
+46.27%
Dec 2025
$8.72
$8.98
-0.11%

Intellia Share Price FAQs